{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:18Z","timestamp":1786119138016,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/fjc.0b013e31818713d6","type":"journal-article","created":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T03:10:13Z","timestamp":1226632213000},"page":"393-402","source":"Crossref","is-referenced-by-count":16,"title":["Tolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and\/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial"],"prefix":"10.1097","volume":"52","author":[{"given":"Aldo P","family":"Maggioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Caterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walmir","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Finer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc Van","family":"Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya M","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant.","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"R2-3-20210208","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1517\/14740338.4.6.1083","article-title":"Safety of obesity drugs.","volume":"4","author":"Greenway","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R4-3-20210208","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.ijo.0802887","article-title":"Influence of sibutramine on blood pressure: evidence from placebo-controlled trials.","volume":"26","author":"Jordan","year":"2005","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R5-3-20210208","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","article-title":"Paradoxical effect of sibutramine on autonomic cardiovascular regulation.","volume":"106","author":"Birkenfeld","year":"2002","journal-title":"Circulation"},{"key":"R6-3-20210208","first-page":"1560","article-title":"Sympathetic vasomotor tone determines blood pressure response to long-term sibutramine treatment. J Clin Endocrinol Metab.","volume":"92","author":"Heusser","year":"2007","journal-title":"April"},{"key":"R7-3-20210208","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clpt.2006.02.002","article-title":"Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.","volume":"79","author":"Heusser","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R8-3-20210208","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehm217","article-title":"Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial.","volume":"28","author":"Torp-Pedersen","year":"2007","journal-title":"Eur Heart J"},{"key":"R9-3-20210208","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/aje\/kwg275","article-title":"Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey.","volume":"158","author":"Onyike","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R10-3-20210208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1358\/dot.2004.40.1.799437","article-title":"Clinical use of sibutramine.","volume":"40","author":"Ryan","year":"2004","journal-title":"Drug of Today"},{"issue":"9248","key":"R11-3-20210208","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"R12-3-20210208","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","article-title":"Long-term weight loss with sibutramine: a randomized controlled trial.","volume":"286","author":"Wirth","year":"2001","journal-title":"JAMA"},{"key":"R13-3-20210208","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(98)00423-9","article-title":"Rationale and design of the International Verapamil SR\/Trandolapril study (INVEST): An internet-based randomized trial in coronary artery disease patients with hypertension.","volume":"32","author":"Pepine","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R14-3-20210208","doi-asserted-by":"crossref","first-page":"25H","DOI":"10.1016\/S0002-9149(98)00488-3","article-title":"Prevention of Events with Angiotensin-Converting Enzyme inhibition (The PEACE study design).","volume":"82","author":"Pfeffer","year":"1998","journal-title":"Am J Cardiol"},{"key":"R15-3-20210208","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1467-789X.2007.00425.x","article-title":"Sibutramine-associated adverse effects: a practical guide for its safe use.","volume":"9","author":"Florentin","year":"2008","journal-title":"Obesity Reviews"},{"key":"R16-3-20210208","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotension-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events.","volume":"12","year":"1996","journal-title":"Can J Cardiol"},{"key":"R17-3-20210208","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/hc1002.105136","article-title":"Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) trial: To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?","volume":"105","author":"Simes","year":"2002","journal-title":"Circulation"},{"key":"R18-3-20210208","first-page":"1064","article-title":"Causes of death in obesity: relevant increase in cardiovascular but not in all-cancer mortality. J Clin Epidemiol.","volume":"59","author":"Bender","year":"2006","journal-title":"October"},{"key":"R19-3-20210208","first-page":"763","article-title":"Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med.","volume":"355","author":"Adams","year":"2006","journal-title":"August"},{"key":"R20-3-20210208","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/oby.2005.219","article-title":"Eligibility for obesity treatment and risk of mortality in men.","volume":"13","author":"Mason","year":"2005","journal-title":"Obes Res"},{"key":"R21-3-20210208","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1001\/archinte.1987.00370100039008","article-title":"Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity.","volume":"147","author":"Messerli","year":"1987","journal-title":"Arch Intern Med"},{"key":"R23-3-20210208","doi-asserted-by":"crossref","first-page":"10F","DOI":"10.1016\/S0002-9149(97)00477-3","article-title":"Frequency of sudden cardiac death and profiles of risk.","volume":"80","author":"Myerburg","year":"1997","journal-title":"Am J Cardiol"},{"key":"R24-3-20210208","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/S0140-6736(99)04383-4","article-title":"Diabetes as a risk factor for sudden death.","volume":"354","author":"Balkau","year":"1999","journal-title":"Lancet"},{"key":"R25-3-20210208","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"R26-3-20210208","first-page":"CD004096","article-title":"Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.","volume":"1","author":"Norris","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-3-20210208","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archinte.164.13.1395","article-title":"Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: A meta-analysis.","volume":"164","author":"Norris","year":"2004","journal-title":"Arch Intern Med"},{"key":"R28-3-20210208","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease.","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"R29-3-20210208","first-page":"369","article-title":"The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: Evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization.","volume":"10","author":"Porter","year":"2004","journal-title":"Am J Manag Care"},{"key":"R30-3-20210208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1473-3099(06)70523-0","article-title":"Obesity and infection.","volume":"6","author":"Falagas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R31-3-20210208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/pgmj.61.713.233","article-title":"Diabetes mellitus and infection.","volume":"61","author":"Larkin","year":"1985","journal-title":"Postgrad Med J"},{"key":"R32-3-20210208","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2337\/diacare.24.6.1044","article-title":"Diabetes and the risk of infection-related mortality in the U.S.","volume":"24","author":"Bertoni","year":"2001","journal-title":"Diabetes Care"},{"key":"R33-3-20210208","first-page":"369","article-title":"Weight loss with sibutramine improves glycemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.","volume":"10","author":"Fujioka","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"R34-3-20210208","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","article-title":"Efficacy and safety of sibutramine in obese white and African American patients with hypertension: A 1-year, double-blind, placebo-controlled, multicenter trial.","volume":"160","author":"McMahon","year":"2000","journal-title":"Arch Intern Med"},{"key":"R35-3-20210208","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000095329","article-title":"Obesity and renal hemodynamics.","volume":"151","author":"Bosma","year":"2006","journal-title":"Contrib Nephrol"},{"key":"R36-3-20210208","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.mnh.0000242172.06459.7c","article-title":"Obesity, proteinuria and progression of renal failure.","volume":"15","author":"Praga","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R37-3-20210208","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000441-200209000-00003","article-title":"Mechanisms of obesity-associated cardiovascular and renal disease.","volume":"324","author":"Hall","year":"2002","journal-title":"Am J Med Sci"},{"key":"R38-3-20210208","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/ndt\/gfg427","article-title":"After all those fat years: renal consequences of obesity.","volume":"18","author":"Wolf","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R39-3-20210208","first-page":"331","article-title":"Obesity and renal disease. Curr Opin Nephrol Hypertens.","volume":"11","author":"Adelman","year":"2002","journal-title":"May"},{"key":"R40-3-20210208","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjhyper.2005.10.002","article-title":"Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.","volume":"19","author":"Bigazzi","year":"2006","journal-title":"Am J Hypertens"},{"key":"R41-3-20210208","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1681\/ASN.2005060638","article-title":"Obesity and risk for chronic renal failure.","volume":"17","author":"Ejerblad","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R42-3-20210208","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/archinte.163.17.2058","article-title":"Depression in association with severe obesity: changes with weight loss.","volume":"163","author":"Dixon","year":"2003","journal-title":"Arch Intern Med"},{"key":"R43-3-20210208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF03327770","article-title":"Increased waist circumference is associated with an increased prevalence of mood disorders and depressive symptoms in obese women.","volume":"12","author":"Moreira","year":"2007","journal-title":"Eat Weight Disord"},{"key":"R44-3-20210208","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.ijo.0802204","article-title":"Prospective association between obesity and depression: Evidence from the Alameda County study.","volume":"27","author":"Roberts","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R45-3-20210208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/aje\/152.2.163","article-title":"Are the obese at greater risk for depression?","volume":"152","author":"Roberts","year":"2000","journal-title":"Am J Epidemiol"},{"key":"R46-3-20210208","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.ijo.0802626","article-title":"Relationship of obesity to depression: A family-based study.","volume":"28","author":"Dong","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R47-3-20210208","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2337\/diacare.15.2.253","article-title":"Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients.","volume":"15","author":"Marcus","year":"1992","journal-title":"Diabetes Care"},{"key":"R48-3-20210208","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archpsyc.55.5.405","article-title":"Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: Report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care.","volume":"55","author":"Gater","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"R49-3-20210208","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/hcl041","article-title":"ORahilly, et al. Psychiatric co-morbidities in patients attending specialist obesity services in the UK.","volume":"99","author":"Tuthill","year":"2006","journal-title":"Q J Med"},{"key":"R50-3-20210208","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1464-5491.2002.00655.x","article-title":"Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy.","volume":"19","author":"Serrano-Rios","year":"2002","journal-title":"Diabet Med"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005344-200811000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:31:24Z","timestamp":1786037484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200811000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e31818713d6","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}